Copyright
©The Author(s) 2015.
World J Gastroenterol. Mar 21, 2015; 21(11): 3206-3213
Published online Mar 21, 2015. doi: 10.3748/wjg.v21.i11.3206
Published online Mar 21, 2015. doi: 10.3748/wjg.v21.i11.3206
Partner protein | Function | Ref. |
EWI-2 | Modulates integrin-dependent cell motility, morphology and/or spreading | [5-6,8,44,45,50] |
EWI-F | Functions unknown | [5-6,8,46,47] |
Integrin β1 | CD9 modulates integrin-dependent cell morphology, cell migration, signaling and adhesion strengthening | [5,11] |
Other tetraspanins (e.g., CD81, CD151) | Form TEMs | [7,8] |
Claudin-1 | CD9 stabilizes expression of non-junctional Claudin-1 | [10] |
EGFR | CD9 enhances the internalization of EGFR and reduces EGF-EGFR-induced signals | [11] |
HB-EGF | CD9 upregulates both diphtheria toxin binding and mitogenic functions of HB-EGF | [23,24] |
PKC isoforms | Contribute to signaling and tumor-suppressor functions | [29] |
Type II PI4K | Contribute to signaling and tumor-suppressor functions | [30] |
- Citation: Murayama Y, Oritani K, Tsutsui S. Novel CD9-targeted therapies in gastric cancer. World J Gastroenterol 2015; 21(11): 3206-3213
- URL: https://www.wjgnet.com/1007-9327/full/v21/i11/3206.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i11.3206